FDA inspection
Huzhou Zhanwang Pharmaceutical Co., Ltd.: FDA inspection ending Mar 29, 2024
FDA inspection 1237589 · No Action Indicated (NAI) · Huzhou
Key facts
| Inspection ID | 1237589 |
|---|---|
| Firm | Huzhou Zhanwang Pharmaceutical Co., Ltd. |
| FEI number | 1000613242 |
| Address | West Development, Rd ; Linghuzhen Nanxun; Linghuzhen Nanxun |
| City | Huzhou |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Mar 29, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data